MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
19.94
+0.30 (1.53%)
At close: Dec 18, 2025, 4:00 PM EST
20.12
+0.18 (0.89%)
After-hours: Dec 18, 2025, 7:07 PM EST
MapLight Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts that cover MapLight Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $31, which forecasts a 55.47% increase in the stock price over the next year. The lowest target is $28 and the highest is $34.
Price Target: $31 (+55.47%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MapLight Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 |
|---|---|
| Strong Buy | 2 |
| Buy | 2 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +40.42% | Nov 21, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +60.48% | Nov 21, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $30 | Buy | Initiates | $30 | +50.45% | Nov 21, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $34 | Buy | Initiates | $34 | +70.51% | Nov 21, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.34
from -105.38
EPS Next Year
-3.74
from -5.34
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -5.39 | -2.74 | |
| Avg | -5.34 | -3.74 | |
| Low | -5.23 | -4.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.